Journal Updates
eMediNexus Coverage from: 
A new treatment rapidly improves hot flashes
eMediNexus,  16 March 2018
remove_red_eye 822 Views
#Obstetrics and Gynecology #Pathology and Lab Medicine #Pharmacist

0 Read Comments                

The oral neurokinin 3 receptor (NK3R) antagonist, MLE4901, rapidly relieved vasomotor symptoms, in particular flashes by 72% by day 3 of treatment vs baseline symptoms and a 51% improvement in frequency with the oral treatment compared with those on placebo. These findings were published March 12, 2018 in the journal Menopause.
Read the full story.
Create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now